Aster DM Healthcare Financial Statements

Switch to
Tabular Data
Graph
Switch to
Consolidated
Standalone
Y/e 31 Mar Mar-2020 Mar-2018 Mar-2017 -
Growth matrix (%)        
Revenue growth 30 13.30 -- --
Op profit growth 105 84.50 -- --
EBIT growth 95.60 688 -- --
Net profit growth 2.88 164 -- --
Profitability ratios (%)        
OPM 14.40 9.12 5.60 --
EBIT margin 8.12 5.40 0.78 --
Net profit margin 3.17 4 1.72 --
RoCE 9.13 6.60 -- --
RoNW 2.27 2.86 -- --
RoA 0.89 1.22 -- --
Per share ratios ()        
EPS 6.30 5.58 2.42 --
Dividend per share -- -- -- --
Cash EPS (6.20) (0.60) (5.50) --
Book value per share 65.50 56.10 46.50 --
Valuation ratios        
P/E 15.20 30 -- --
P/CEPS (15) (293) -- --
P/B 1.46 2.98 -- --
EV/EBIDTA 7.87 15.90 -- --
Payout (%)        
Dividend payout -- -- -- --
Tax payout (4.40) (15) 3.52 --
Liquidity ratios        
Debtor days 81.70 77 -- --
Inventory days 33.20 31.30 -- --
Creditor days (72) (64) -- --
Leverage ratios        
Interest coverage (2) (2) (0.10) --
Net debt / equity 1.66 0.72 1.39 --
Net debt / op. profit 4.32 3.35 7.85 --
Cost breakup ()        
Material costs (30) (31) (32) --
Employee costs (33) (34) (35) --
Other costs (22) (26) (28) --
Switch to
Tabular Data
Graph
Switch to
Consolidated
Standalone
Y/e 31 Mar( In .Cr) Mar-2020 Mar-2018 Mar-2017 -
Revenue 8,739 6,721 5,931 --
yoy growth (%) 30 13.30 -- --
Raw materials (2,635) (2,059) (1,887) --
As % of sales 30.20 30.60 31.80 --
Employee costs (2,904) (2,271) (2,055) --
As % of sales 33.20 33.80 34.60 --
Other costs (1,941) (1,778) (1,657) --
As % of sales 22.20 26.50 27.90 --
Operating profit 1,258 613 332 --
OPM 14.40 9.12 5.60 --
Depreciation (586) (298) (322) --
Interest expense (360) (185) (354) --
Other income 37.90 47.70 36.40 --
Profit before tax 350 178 (308) --
Taxes (15) (26) (11) --
Tax rate (4.40) (15) 3.52 --
Minorities and other (38) (13) 4.23 --
Adj. profit 296 139 (314) --
Exceptional items (20) 130 416 --
Net profit 277 269 102 --
yoy growth (%) 2.88 164 -- --
NPM 3.17 4 1.72 --
Switch to
Tabular Data
Graph
Y/e 31 Mar ( In .Cr) Mar-2020 Mar-2018 Mar-2017 -
Profit before tax 350 178 (308) --
Depreciation (586) (298) (322) --
Tax paid (15) (26) (11) --
Working capital 508 -- -- --
Other operating items -- -- -- --
Operating cashflow 257 (146) -- --
Capital expenditure 4,703 -- -- --
Free cash flow 4,960 (146) -- --
Equity raised 4,065 4,385 -- --
Investments 2.03 -- -- --
Debt financing/disposal 2,973 110 -- --
Dividends paid -- -- -- --
Other items -- -- -- --
Net in cash -- 4,349 -- --
Switch to
Tabular Data
Graph
Switch to
Consolidated
Standalone
Y/e 31 Mar ( In .Cr) Mar-2020 Mar-2019 Mar-2018 Mar-2017
Equity capital 874 880 880 841
Preference capital -- -- -- --
Reserves 2,398 2,334 1,952 1,034
Net worth 3,272 3,214 2,832 1,875
Minority interest
Debt 5,605 2,788 2,352 2,758
Deferred tax liabilities (net) 374 349 300 144
Total liabilities 9,698 6,818 5,842 5,152
Fixed assets 7,860 4,839 4,140 3,809
Intangible assets
Investments 34.40 22.10 37.70 32.30
Deferred tax asset (net) 252 208 163 3.03
Net working capital 1,375 1,407 1,202 1,155
Inventories 961 732 627 526
Inventory Days 40.10 -- 34.10 32.30
Sundry debtors 2,366 2,029 1,546 1,288
Debtor days 98.80 -- 84 79.20
Other current assets 1,007 965 828 997
Sundry creditors (1,818) (1,387) (1,146) (1,003)
Creditor days 75.90 -- 62.20 61.70
Other current liabilities (1,141) (932) (655) (652)
Cash 177 341 300 152
Total assets 9,698 6,818 5,842 5,152
Switch to
Consolidated
Standalone


Particulars ( Rupees In Crores.) Jun-2020 Mar-2020 Dec-2019 Sep-2019 Jun-2019
Gross Sales 1,761 2,301 2,322 2,087 2,029
Excise Duty -- -- -- -- --
Net Sales 1,761 2,301 2,322 2,087 2,029
Other Operating Income -- -- -- -- --
Other Income 7.54 26.80 4.18 4.40 3.25
Total Income 1,768 2,328 2,326 2,091 2,032
Total Expenditure ** 1,618 1,899 1,955 1,842 1,806
PBIDT 150 429 371 249 226
Interest 80.30 112 71.50 88.40 87.70
PBDT 70 317 299 161 138
Depreciation 155 171 140 149 126
Minority Interest Before NP -- -- -- -- --
Tax 4.74 14.40 4.65 6.19 2.79
Deferred Tax (0.90) (14) 3.59 (1.20) (0.60)
Reported Profit After Tax (89) 146 151 6.87 10.10
Minority Interest After NP (5.70) 15.20 12.30 3.75 6.79
Net Profit after Minority Interest (83) 131 139 3.12 3.26
Extra-ordinary Items -- (1.10) (17) -- --
Adjusted Profit After Extra-ordinary item (83) 132 157 3.12 3.26
EPS (Unit Curr.) (1.70) 2.61 2.78 0.06 0.06
Book Value (Unit Curr.) -- -- -- -- --
Dividend (%) -- -- -- -- --
Equity 500 500 505 505 505
Public Shareholding (Number) -- -- -- -- --
Public Shareholding (%) -- -- -- -- --
Pledged/Encumbered - No. of Shares -- -- -- -- --
Pledged/Encumbered - % in Total Promoters Holding -- -- -- -- --
Pledged/Encumbered - % in Total Equity -- -- -- -- --
Non Encumbered - No. of Shares -- -- -- -- --
Non Encumbered - % in Total Promoters Holding -- -- -- -- --
Non Encumbered - % in Total Equity -- -- -- -- --
PBIDTM(%) 8.54 18.70 16 11.90 11.10
PBDTM(%) 3.98 13.80 12.90 7.71 6.82
PATM(%) (5) 6.36 6.52 0.33 0.50